BioForward Member Directory

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

Imbed Biosciences, Inc. is a privately held medical device company developing novel and patent-pending technologies for imbedding bio-active molecules in wound dressings and surgical implants. The company was founded in December 2010 by a multidisciplinary group of engineers, veterinary scientists and medical surgeons. Imbed's vision is to bring next-generation wound dressings and surgical meshes into clinics to prevent infections and expedite wound closure, and reduce the overall cost of managing surgical and chronic wounds.

Immuto Scientific is an AI-enabled therapeutics company discovering disease-specific targets defined by changes in protein structure on the cell surface and developing advanced antibody-based medicines against them. Its structural surfaceomics platform measures these conformational changes across cell-surface proteins in living, disease-relevant systems, generating proprietary data that conventional genomics, expression-based approaches, and standard surface mapping can’t capture. Immuto uses AI to prioritize targets, build conformational models informed by empirical data and available structural models, and optimize antibodies for affinity and developability. Using this approach, Immuto is advancing a proprietary pipeline of antibody therapeutics alongside partnered programs with pharmaceutical companies, with an initial focus in oncology.

‍

Biotechnology company, core technology is bovine sperm sorting.

International Flavors and Fragrances combines in-depth knowledge with current research and expert science to deliver unmatched value to the food and health industries.

Intuitive Biosciences specializes in (1) assay development and manufacturing and (2) non-human primate disease screening.  We develop molecular and immunoassays for infectious, autoimmune, and bacterial diseases and cancer detection.  We partner with labs and other companies for test development on multiple test platforms to produce either research use only or clinical diagnostics.  Our non-human primate tests screen for diseases and are run as a service in our lab and at customer facilities in the U.S., Asia, and Europe.  Intuitive Biosciences is based in Madison, Wisconsin.

Invenra is developing next generation, multispecific antibody therapeutics based on our high-performance B-Body® Platform. With an initial focus in oncology, we and our partners are currently advancing pipelines of novel bi- and multispecific antibody candidates. With our growing portfolio of innovative therapeutic approaches and best in class clinical antibody screening and development platform, we intend to expand our pipeline across additional disease categories, creatively optimizing candidates to address even the most challenging of therapeutic targets.

We support biotech, med device, healthcare organization and startups with fractional C-suite (CEO, CTO, CGO) leadership skillsets, technology consulting, implementation, QA, support, managed services, and staffing related to IT Strategy, Data and Analytics, EHR Data and Integration, Research and clinical trials enablement, Cloud transformation and modernization, Consumer engagement, Cyber Security, HIPAA/SOC2 IT Compliance, Application and Mobile app development capabilities.

Isthmus Project, a subsidiary of UW Health in Madison, Wisconsin, serves as an innovation hub working with UW Health System and UW School of Medicine and Public Health innovators, including faculty physicians, scientists, residents, science trainees, nurses, and staff, to bring innovative healthcare solutions to market.

JangoBio is a pre-clinical stage biotech located in Madison, WI. The company was formed in 2015 to advance novel regenerative medicines for treatment of reproductive hormone imbalance and associated age-related conditions.

Keenova is a therapeutics company with deep roots in targeted, specialty treatments. We deliver medicines grounded in science and guided by our commitment to responsible practices.

We focus on areas of medicine where patients face gaps in treatment options, working with payors and providers to help connect patients with the therapies they need and rely on. Driven by real challenges, we strive to serve patients through experience, evidence, and a steadfast commitment to delivering with integrity.

Kendrick Labs has been carrying out protein electrophoresis as a service for academia, NIH and biotech companies since 1987. Our mission is to help clients solve proteomic problems quickly and economically, especially problems which require 2-dimensional gel electrophoresis. Our service functions nationwide via low-cost express mail, toll-free phone, and e-mail.

The Kenosha Area Business Alliance (KABA) is the lead economic development organization for Kenosha County, WI. The KABA team leads initiatives that position Kenosha County as the premier destination for investment, job creation, and talent in the Chicago-Milwaukee corridor. KABA provides concierge support to existing and prospective businesses through a variety of services including real estate site selection, incentive navigation, and talent pipeline development. KABA also hosts a variety of events, programs, and trainings to provide timely and actionable information to the business community.

‍